Analysts Set Aspen Aerogels, Inc. (NYSE:ASPN) PT at $19.00

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have been assigned a consensus rating of “Buy” from the five ratings firms that are covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $19.00.

Several brokerages recently weighed in on ASPN. Canaccord Genuity Group boosted their target price on Aspen Aerogels from $13.00 to $17.00 and gave the stock a “buy” rating in a research note on Wednesday, December 27th. HC Wainwright reaffirmed a “buy” rating and set a $20.00 price target on shares of Aspen Aerogels in a research report on Wednesday, February 14th. TheStreet upgraded Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. Canaccord Genuity Group raised their price objective on Aspen Aerogels from $13.00 to $17.00 and gave the stock a “buy” rating in a research note on Wednesday, December 27th. Finally, Roth Mkm began coverage on Aspen Aerogels in a research report on Wednesday, March 6th. They issued a “buy” rating and a $22.00 target price on the stock.

Institutional Trading of Aspen Aerogels

Several hedge funds and other institutional investors have recently bought and sold shares of ASPN. Rice Hall James & Associates LLC raised its stake in shares of Aspen Aerogels by 385.0% during the 3rd quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company’s stock worth $5,359,000 after buying an additional 494,662 shares during the period. Vanguard Group Inc. raised its holdings in Aspen Aerogels by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 3,445,887 shares of the construction company’s stock valued at $29,635,000 after buying an additional 14,013 shares during the period. Principal Financial Group Inc. acquired a new stake in Aspen Aerogels in the 3rd quarter valued at approximately $449,000. Maven Securities LTD purchased a new stake in shares of Aspen Aerogels in the 3rd quarter valued at $860,000. Finally, Worth Venture Partners LLC acquired a new stake in shares of Aspen Aerogels during the third quarter worth about $3,684,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Stock Up 1.4 %

Shares of NYSE ASPN opened at $15.17 on Friday. The stock has a market capitalization of $1.16 billion, a PE ratio of -22.98 and a beta of 2.04. The company has a current ratio of 3.41, a quick ratio of 2.91 and a debt-to-equity ratio of 0.24. Aspen Aerogels has a 12-month low of $5.32 and a 12-month high of $19.10. The stock’s fifty day simple moving average is $16.52 and its two-hundred day simple moving average is $13.15.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.11. The company had revenue of $84.22 million for the quarter, compared to the consensus estimate of $83.82 million. Aspen Aerogels had a negative return on equity of 10.47% and a negative net margin of 19.19%. During the same quarter last year, the company earned ($0.20) earnings per share. As a group, analysts expect that Aspen Aerogels will post -0.24 EPS for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.